HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Uranium, bis(formato-kappaO)dioxo-, (T-4)-

HCID 86897
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
16984-59-1
Standard SMILES
O=CO.O=CO.[O]=[U]=[O]
InChIKey
SFIHWLKHBCDNCE-UHFFFAOYSA-N
Molecular formula
C2H4O6U
Average molar mass
362.08 g/mol
Monoisotopic mass
362.05157

Overview

Uranyl formate is a chemical compound of uranium. Uranium is a chemical element that has the symbol U and atomic number 92. It is a normal part of rocks, soil, air, and water, and occurs in nature in the form of minerals. (L248, L249)

Names & identifiers

Preferred name
Uranium, bis(formato-kappaO)dioxo-, (T-4)-
IUPAC
dioxouranium;formic acid

Names & synonyms

dioxouranium;formic acidUranium, bis(formato-kappaO)dioxo-, (T-4)-EINECS 241-063-6

Database identifiers

CAS
16984-59-1
PubChem CID
86897

Properties

Computed structural properties

Topological polar surface area
109 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
6
Rotatable bonds
0
Heavy atoms
9
Formal charge
0
Complexity
71.5

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety & protection

Minimum Risk Level · 1 item

Intermediate Inhalation: 0.0004 mg/m3 (Soluble uranium salts) (L134) Chronic Inhalation: 0.0003 mg/m3 (Soluble uranium salts) (L134) Intermediate Oral: 0.002 mg/kg/day (Soluble uranium salts) (L134) Intermediate Inhalation: 0.008 mg/m3 (Insoluble uranium compounds) (L134)

Toxicology

Health Effects · 1 item

Uranium primarily damages the kidney, but may also damage the lungs, central nervous system, and immune system. Uranium's radioactivity is believed to damage the DNA, resulting in carcinogenic effects and reproductive and developmental damage. (L248, L249)

Exposure RoutesOral (L249) ; inhalation (L249) ; dermal (L249)
Toxicity Summary · 1 item

Uranium is combined with either bicarbonate or a plasma protein in the blood but once in the kidney, it is released and forms complexes with phosphate ligands and proteins in the tubular wall, causing damage. Uranium may also inhibit both sodium transport-dependent and independent ATP utilization and mitochondrial oxidative phosphorylation in the renal proximal tubule. Uranium causes respiratory diseases by damaging alveolar epithelium type II cells in the lungs. Uranium induces c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK) activation, which in turn induces tumor necrosis factor alpha (TNF-alpha) secretion and generates and inflammatory response in the lungs. Studies have shown that the more soluble the uranium salt, the more toxic it is. Ionizing radiation produced by uranium damages the DNA, resulting in gene mutations and chromosomal aberrations. This can both both initiate and promote carcinogenesis, and interfere with reproduction and development. (L249, A160)

Signs and SymptomsIngestion of uranium may cause vomiting and diarrhea. (L248)

Chemistry & industry

Pharmacology

Metabolism/Metabolites · 1 item

Uranium is absorbed in low amounts via oral, inhalation, and dermal routes. Uranium in body fluids generally exists as the uranyl ion (UO2)2+ complexed with anions, such as citrate and bicarbonate, or plasma proteins. Uranium preferentially distributes to bone, liver, and kidney. The large majority of uranium that enters the body is not absorbed and is eliminated from the body via the urine and faeces. (L248)

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Carcinogen ClassificationUranium: Group 1, carcinogenic to humans (L135)